Gated metabolic positron emission tomography (gapet) of the myocardium 18f-fdg-pet to optimize recognition of myocardial hibernation

Nuclear Medicine Communications

Volumn 19, Issue 6, 1998, Pages 535-545

  HOR G ^a   Kranert, W T ^a   Maul, F D ^a   SchrODer O ^a   Karimian Tatriz, A ^a   Geb, O ^a   Baum, R P ^a   Scherer, U W ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; HEART CINEVENTRICULOGRAPHY; HEART EJECTION FRACTION; HEART MOVEMENT; HEART MUSCLE; HUMAN; POSITRON EMISSION TOMOGRAPHY;

CORONARY DISEASE; FIBROSIS; FLUORODEOXYGLUCOSE F18; GATED BLOOD-POOL IMAGING; HEART; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL STUNNING; MYOCARDIUM; RADIOPHARMACEUTICALS; REFERENCE VALUES; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031822914     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199806000-00005     Document Type: Article

References (28)

1. Marwick Th, D’Hondt AM, Baudhuin Th et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: Combination with echocardiography or scintigraphy, or both? Am J Cardiol 1993; 22: 159-167.
2. Hor G. What is the current status of quantification and nuclear medicine in cardiology? Eur J Nucl Med 1996; 23: 815-851.
3. Pitt B, Strauss HW. Myocardial perfusion imaging and gated cardiac blood pool scanning: Clinical application. Am J Cardiol 1976; 38: 739-746.
4. Bisi G, Scigara R, Bull U et al. Assessment of ventricular function with first-pass radionuclide angiography using technetium 99m hexakis-2-methoxyisobutylisonitrile: A European multicentre study. Eur J Nucl Med 1991; 18: 178-183.
5. Borges-Neto S, Coleman RE, Jones RH. Perfusion and function at rest and treadmill exercise using technetium-99m-sestamibi: Comparison of one-and two-day protocols in normal volunteers. J Nucl Med 1990; 31: 1128-1132.
6. Goris ML, Thompson C, Malone LM, Franken PR. Modelling the integration of regional perfusion and function. Nucl Med Commun 1994; 15: 9-20.
7. Hoffman EJ, Phelps ME, Wisenberg G, Schelbert HR, Kuhl DE. Electrocardiographic gating in positron emission computed tomography. J Comput Assist Tomogr 1979; 3: 733-739.
8. Yamashita K, Tamaki N, Yonekura Y, Ohtani H. Quantitative analysis of regional wall motion by gated myocardial positron emission tomography: Validation and comparison with left ventriculography. J Nucl Med 1989; 30: 1775-1786.
9. Yamashita K, Tamaki N, Yonekura Y et al. Regional wall thickening of left ventricle evaluated by gated positron emission tomography in relation to myocardial perfusion and glucose metabolism. J Nucl Med 1991; 32: 679-685.
10. Hör G, Maul FD, Kranert WT et al. Simultaneous determination of myocardial wall thickening and regional EF by PET: Preliminary results (abstract). J Nucl Cardiol 1995; 2: S117.
11. Hoffmeister HM, Müller-Schauenburg W, Helber U, Feine U, Seipel L. EKG-getriggerte FDG-Positron-Emissions-Computertomographie zur Identifikation von vitalem Myokard (abstract). Zschr Kardiol 1995; 1: 3.
12. Porenta G, Kuhle W, Sinha S et al. Parameter estimation of cardiac geometry by ECG-gated PET imaging: Validation using magnetic resonance imaging and echocardiography. J Nucl Med 1995; 36: 1123-1129.
13. Bom HS, Vansant JP, Pettigrew RI, Cooke CD, Garcia EV. Can gated F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) determine myocardial viability without N-13 ammonia (NH3)? (abstract). 7th Annual International PET Conference of the ICP, San Francisco, 1995: S19.
14. Landoni C, Bettinardi V, Lucignani G, Gilardi MC, Striano G, Fazio F. A procedure for wall detection in F-18-FDG positron emission tomography heart studies. Eur J Nucl Med 1996; 23: 18-24.
15. Knuuti MJ, Nuutila P, Ruotsalainen U et al. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. J Nucl Med 1993; 34: 2068-2075.
16. Tennant R, Wiggers CJ. Effect of coronary occlusion on myocardial contraction. Am J Physiol 1935; 112: 351.
17. Herman MV, Heinle RA, Klein MD, Gorlin R. Localized disorders in myocardial contraction: Asynergy and its role in congestive heart failure. N Engl J Med 1967; 277: 222-232.
18. Schwarz ER, Schaper J, vom Dahl J et al. Myocyte degeneration and cell death in hibernating human myocardium. J Am Coll Cardiol 1996; 27: 1577-1585.
19. Perrone-Filardi P, Bacharach SL, Dilsizian V, Maurea S, Frank JA, Bonow RO. Regional left ventricular wall thickening. Circulation 1992; 86: 1125-1137.
20. Miller TR, Wallis JW, Landy BR, Gropler RJ, Sabharwal CL. Measurement of global and regional ventricular function by cardiac PET. J Nucl Med 1994; 35: 999-1005.
21. Gewirtz H, Grotte GJ, Strauss HW et al. The influence of left ventricular volume and wall motion on myocardial images. Circulation 1979; 59: 1172-1177.
22. Sechtem U, Schicha H. Kardiale Diagnostik mit konventioneller Szintigraphie, Positronen-Emissionstomographie und Kernspintomographie. Med Klin 1993; 88: 540-542.
23. Pechock RM, Rokey R, Malloy CM et al. Assessment of myocardial systolic wall thickening using nuclear magnetic resonance imaging. J Am Coll Cardiol 1989; 14: 653-659.
24. Araujo LI, Lammertsma AA, Rhodes CG et al. Noninvasive quantification of regional myocardial blood flow in coronary artery disease with oxygen-15-labeled carbon dioxide inhalation and positron emission tomography. Circulation 1991; 83: 875-885.
25. Yamamoto Y, de Silva R, Rhodes CG, Araujo LI, Ida H, Rechavia E. A new strategy for the assessment of viable myocardium and regional myocardial blood flow using O-15-water and dynamic positron emission tomography. Circulation 1992; 86: 167-178.
26. Büll U, Foroutan Y, Hellwig D et al. Vergleich von relativer 18-F-FDG-Aufnahme mit metabolischer Rate (MR Glukose) im Myokard bei KHK, klassifiziert mit 99Tcm-MIBI. Nuklearmedizin 1995; 34: 223-228.
27. Reifart N, Maul FD, Mützel E et al. Aortokoronare Bypassoperation bei erheblich reduzierter linksventrikulärer Funktion infolge chronischer Ischämie. Dtsch Med Wschr 1984; 109: 1671-1677.
28. Gould KL. PET perfusion imaging and nuclear cardiology. J Nucl Med 1991; 32: 579-606.